News

According to the company, this new molecular diagnostic tool marks a major advancement in which medical treatments can be personalized to patients diagnosed with this deforming disease. The

NeuVax contains the E75 peptide which is one of the rare T-cell peptides that has been documented to elevate or boost pre-existing anti-cancer immunity in cancer patients. This

Mr Frederick brings to NovaRay 20 years of financial leadership in strategic planning, financial reporting, mergers, acquisitions and international finance. Prior to joining NovaRay, Mr Frederick was senior

According to the company, the test has a reported sensitivity of 97%, and a specificity of 91% in identifying squamous cell lung cancer. Classification accuracy was measured in

The project between Scynexis and Drugs for Neglected Diseases initiative (DNDi) was initiated in 2006 and will now run through March 2012. The collaboration includes partners at Pace

The financing includes funding from several angel networks including Bellingham Angels, Alliance of Angels, Keiretsu, Tacoma Angel Network and Zino Society. Robert Brown, CEO of Healionics, said: “This

ProStrakan now plans to launch Abstral in Germany and the UK in the first few weeks of 2009, with further launches across Europe during the year. Abstral (formerly

Infinity’s heat shock protein 90 (Hsp90) program comprises IPI-504 (retaspimycin hydrochloride for injection) and oral IPI-493. IPI-504 is in several clinical trials, including an international Phase III registration

Hovione Cork will employ 70-80 staff and will, over the next 24 months, be transferring products from its Loures, Portugal site and validating processes for new compounds in